Business Wire

Galderma Campaign “Proof in Real Life”: Patients Tell their Stories One Year Later

Del

In 2015, Sharon Stone, signed on to the “Proof in Real Life” campaign to help Galderma challenge common misconceptions of aesthetic treatments.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161006006286/en/

(Photo: Business Wire)

(Photo: Business Wire)

Galderma & Sharon Stone unveiled the natural-looking results of Restylane fillers and Restylane Skinboosters in a unique real-life format in Berlin, Germany. The Galderma Proof in Real Life campaign launch event saw ten pairs of identical twins take part in a unique challenge. One twin from each pair received a bespoke treatment plan which consisted of treatments with Restylane fillers, Restylane Skinboosters, or a combination of both. Twelve months on from the original campaign, both twins have now been treated.

Galderma met with them and asked them about their expectations, the results and their feelings, having all received the treatment.

Valuable Insights from the Twins and Aesthetic Professionals

To document their reactions, Galderma has launched a new film containing interviews with a number of the twins as well as insights from leading industry experts, featuring Plastic Surgeons, Dermatologists and Aesthetic Physicians.

It was quite an amazing journey for all of us, to be honest”, said Dr. Kuldeep Minocha, the aesthetic practitioner based in London, UK, who performed the treatments. “What was interesting is that all bar one of the sets of twins were treatment naïve. So, they hadn’t had any kind of injectables before. This was a very new step for them.

“So we took a lot of time in understanding what they felt about their skin and skin ageing. We educated them a little bit about the use of injectables, and talked to them about the various properties of what we could do with fillers to try and improve their skin but maintaining things as natural as possible. I think that was the biggest key, particularly when you’re treating patients who are naïve and who have not had any previous treatment and they don’t want too much change. So everything we want to do is to refresh the skin and make them look like the best versions of themselves.”

In the interview, Kelly, one of the twins treated in 2015, described the reactions.

“When I looked in the mirror after my treatments, I was really happy with the results. I was amazed how natural my skin looked, how natural my overall look was, so I was very pleased with what I saw, definitely. A lot of people said, ’You look really fresh, youthful, you’re glowing.’”

Agreement on the Importance of Natural Looking Results

One of the featured elements of the campaign was the focus on achieving natural- looking results. Dr. Van Park, a leading Cosmetic Physician from Sydney, Australia gave her views on patient expectations. “A natural looking result, to me, is undetectable. In my experience, when patients come and see me, they expect to become a better version of themselves. To look the best they can for as long as they can, rather than trying to look 20 years younger. They just want to look fresher and less tired.”

The interviewed professionals agree on this point. Dr. Marie-Thérèse Bousquet, who has worked with aesthetic medicine since 1992, says, “Natural beauty is essential for my patients and for me. They do not want their treatment to be seen.” She continues, “To achieve natural looking results, here is my way of working: I associate different treatments; I never over-correct; I am able to say “no” to the patient. My goal is an improvement of the face without being excessive.”

“Proof in Real Life” of Confidence and Self-Esteem

Another key focus area in the Proof In Real Life Campaign was learning about how patients felt about themselves after treatment.

“Patients often come to me saying they want something to make them look better, but the reality is that they’re asking for something to make them feel better,” says Dr. Steven Dayan, a facial Plastic Surgeon from Chicago, USA. “Perfection of beauty does not equal happiness. What we are actually trying to achieve is to make people feel better about themselves. That’s self-esteem.”

One of the twins, Amie, summed up her experience very eloquently: “I think the main thing people noticed in me after treatment was the confidence I had in myself.”

“The ‘Proof in Real Life’ Campaign has provided some remarkable insights into aesthetic treatments, how achievable and natural-looking these results can be,” said Anne-Sophie Copin, from Galderma. “It has highlighted the important positive effects that aesthetic treatment seem to have, not only on the outside, but also for patients’ confidence, well- being and self-esteem.”

Dr. Steven Dayan sees these kinds of results as central: “This all falls within the realm of what we do as Aesthetic Physicians.” Dr. Dayan concludes, “Restylane has been around for 20 years; it has been on the market in the U.S. since 2003. I’m very comfortable with Restylane and all its capabilities – we understand [Restylane] very well.

Experience for yourself how the twins reacted. Watch Galderma’s film “Proof in Real Life, Twelve Months On”: www.restylane.com

About Galderma:

Dating back to 1961, Galderma is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails.

About Restylane:

Restylane is a range of Hyaluronic Acid (HA) dermal fillers for facial aesthetic treatments to efficiently reduce lines, folds and wrinkles, create fuller lips, enhance contours and facial volume, as well as improve skin quality, structure and elasticity. Restylane has an established safety profile based on over 2 decades of experience and extensive clinical documentation.

Today, with over 28 million treatments worldwide, Restylane is known for natural-looking results with long-lasting effects and high patient satisfaction. The Restylane range is designed to complement the varying stages of facial aging for truly individualized treatments that suit all patient needs.

Within the Restylane range there are two main product ranges:

  • Restylane fillers, designed to enhance and restore facial features, from targeted superficial filling of wrinkles to deeper facial shaping and contouring.
  • Restylane Skinboosters, a progressive approach to improved skin condition, designed to restore the skin’s hydrobalance and refresh the appearance.

Links:

“Proof in Real Life”, Twelve Months On: www.restylane.com

Galderma Launches “Proof in Real Life”: http://proofirl.com/nu/

Legal Disclaimer:
As for all injection treatments using hyaluronic acid dermal fillers, side effects may occur in association with treatment. These side effects are usually mild to moderate, and include transient reactions such as redness, pain, swelling, bruising and/or bumps at the injection sites. Please consult your physician for additional information.
The reactions mentioned in this release are based on the individual’s own experiences and opinions and may not be what others will experience.
“Proof in Real Life” is not being activated in the US.
Restylane, Restylane Skinboosters and Galderma are trademarks of Nestlé Skin Health S.A.

© Nestlé Skin Health S.A. June 2016

Contact information

Galderma
Mårten Forrest
Head of PR & Communication
Aesthetic & Corrective Business
Mobile: +46 768 98 1106
E-mail: marten.forrest@galderma.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Boston Capital Announces Closing of Boston Capital Income & Value U.S. Apartment Fund17.7.2018 14:00Pressemelding

Boston Capital, the third largest owner of apartments in the U.S. with over $19.6 billion invested, is pleased to announce the final investor closing of Boston Capital Income and Value U.S. Apartment Fund (“BCIV”). BCIV, a discretionary multi-investor Luxembourg based fund vehicle, includes financial institutions, insurance companies, pensions, and family offices among its investors and will acquire over $350 million in apartment properties throughout the U.S. “We are very pleased to close BCIV, the latest in a succession of institutional investment vehicles through Boston Capital’s conventional apartment investment arm, Boston Capital Real Estate Partners (“BCRE”),” said Jeff Goldstein, COO and Director of Real Estate at Boston Capital. The Fund generates high current dividends and capital growth by acquiring and renovating Class B apartment properties located in major and secondary U.S. markets and by targeting a renovated rental price point well below new construction rates, which a

Amobee Wins Auction Process to Acquire Videology Assets17.7.2018 13:13Pressemelding

Singtel subsidiary Amobee, a leading global digital marketing technology company serving brands and agencies, today announced that it has emerged as the winner in the court supervised auction to acquire certain assets from Videology, a software provider for advanced TV and video advertising, for purchase price of approximately US$101 million1. The purchase price is subject to adjustments for accounts receivable at closing, estimated to be approximately US$20.9 million. The acquisition, following Videology’s voluntary Chapter 11 restructuring proceedings, includes Videology’s technology platform, intellectual property and certain other assets of estimated net book value of US$5.3 million2. Over the past decade, Videology has emerged as a leading provider of software that empowers advertisers and publishers to use data to optimize campaigns and spend across digital platforms and television. The addition of Videology’s capabilities will be a further boost to Amobee’s omni-channel platform

Lenovo Leaps Forward with Next-Generation ThinkAgile Composable Cloud Platform17.7.2018 12:00Pressemelding

Lenovo Data Center Group (HKSE: 992) (ADR: LNVGY), one of the fastest growing hyperconverged infrastructure (HCI) vendors according to IDC, – with HCI revenue growing at almost twice the market growth rate in Q1 2018 (149.1% compared to 76.3%)—is further expanding its ThinkAgile portfolio to provide an innovative solution for customers who desire the agility of the public cloud and the security of a private cloud. To address this growing customer trend, Lenovo – together with Cloudistics – has developed the ThinkAgile CP Series composable cloud platform, a ‘cloud-in-a-box’ that offers all of the conveniences and ease-of-use of a public cloud environment secured behind the customer’s own data center firewall. Lenovo ThinkAgile CP Series – with fully-integrated infrastructure, application marketplace and end-to-end automation of software-defined network, compute and storage – delivers a turnkey cloud experience that can be easily and centrally managed from anywhere through a software-as-

JPMorgan Chase Bank launches offering of cash-settled exchangeable bonds into Ping An Insurance (Group) Company of China Limited due 202017.7.2018 12:00Pressemelding

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933) OR IN OR INTO JAPAN, THE PEOPLE’S REPUBLIC OF CHINA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. JPMorgan Chase Bank, N.A. (the “Issuer”) today announces the launch of an offering of cash-settled exchangeable bonds due 2020 (the “Bonds”) in aggregate principal amount of up to approximately USD 350 million. The Bonds are referable to H-shares (the “Shares”) of Ping An Insurance (Group) Company of China Limited (the “Company”). Exchange rights in respect of the Bonds will be cash-settled only. The Issuer is rated A+ (Stable outlook) by Standard & Poor’s, Aa3 (Stable outlook) by Moody’s and AA (Stable outlook) by Fitch. The Bonds will be issued in principal amounts of USD 200,000 and integral multiples of USD 100,000 in excess thereof and will not bear interest.

Greene Tweed Achieves Nadcap Accreditation for Non-Metallic Materials Testing17.7.2018 11:01Pressemelding

Greene Tweed’s Central Engineering (CE) Materials Test Lab recently completed its final Nadcap accreditation audit for Non-Metallic Materials Testing (NMMT) of composite materials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180717005200/en/ Greene Tweed Achieves Nadcap Accreditation (Photo: Greene Tweed) In support of Aerospace’s strategic initiative, this positions Greene Tweed as one of a select few aerospace companies who have attained this accreditation as validation of our materials testing capabilities and our position as a composite solutions provider. To achieve this standard, Greene Tweed’s CE lab completed a comprehensive audit against the highest standards for special process controls, test completion, and validation. This in-house accreditation adds to Greene Tweed’s responsiveness to new product development requests while expanding production material and customer product certification capabilities. It also

Norsk Titanium Collaborates with QuesTek Innovations LLC17.7.2018 11:00Pressemelding

Norsk Titanium (Norsk) and QuesTek Innovations LLC (QuesTek) announce a collaborative effort to test novel titanium alloys for applicability in additive manufacturing processes. As part of this collaboration, the companies are evaluating a QuesTek-designed titanium alloy using Norsk’s Rapid Plasma Deposition™ (RPD™) process. Preliminary evaluation of the alloy is complete and Norsk has manufactured initial test specimens. The test program will characterize the alloy microstructure, provide initial material properties, and will confirm QuesTek’s Ti alloy performance using Norsk’s proven production process. QuesTek’s patented titanium alloy has previously demonstrated approximately 15% greater strength and improved ductility over traditional Ti-6Al-4V in both wire-based Electron Beam Additive Manufacturing and traditional casting processes. "We are excited to be working closely with Norsk Titanium’s business and technical team to evaluate our alloy in their proven process. Based on our i